Recent Advances in Breast Cancer Treatments: An Overview
Breast cancer has the second high prevalence among all types of cancer in the US. The average risk of a woman developing it and dying from the disease stands at 13% and 2.6%, making it the second leading cause of cancer death in women.
Breast cancer subtypes are defined by their histopathological appearance and expression of hormone receptors (HR) and growth factors, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).
Recent advances in breast cancer treatments provide more approaches to improve the progression-free survival and overall survival rates in patients; developing new agents and strategies can improve drug resistance and efficacy in current treatment. Breast cancer treatments are majorly decided by the cancer stage, subtype, patient's overall health, menopause status, and cancer growth rate.
Breast cancer subtypes are defined by their histopathological appearance and expression of hormone receptors (HR) and growth factors, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).
Recent advances in breast cancer treatments provide more approaches to improve the progression-free survival and overall survival rates in patients; developing new agents and strategies can improve drug resistance and efficacy in current treatment. Breast cancer treatments are majorly decided by the cancer stage, subtype, patient's overall health, menopause status, and cancer growth rate.
GO Prime with only $1.49 now
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02